NewsBenzinga强生公布其 TREMFYA 用于治疗克罗恩病的 3 期 GALAXI 2、3 试验三年数据，显示疗效和一致的安全性特征 强生公布其 TREMFYA 用于治疗克罗恩病的 3 期 GALAXI 2、3 试验三年数据，显示疗效和一致的安全性特征 Benzinga 2026.10.12 20:12 (GMT+0) Open on Benzinga Other news Wells Fargo Maintains Equal-Weight on PENN Entertainment, Lowers Price Target to $22 HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $85 Price Target Alphabet Stock Rises: What's Going On? $1000 Invested In Agilent Technologies 10 Years Ago Would Be Worth This Much Today Wells Fargo Maintains Equal-Weight on MGM Resorts International, Lowers Price Target to $29 Why Is Applied Digital Stock Surging on Monday?
